Platelet Growth Factors from Allogeneic Platelet-Rich Plasma for Clinical Improvement in Split-Thickness Skin Graft
This preliminary study was carried out to explore whether platelet growth factors from platelet rich plasma could be used for enhancement of split thickness skin graft survival.
New Requirements for an Individualized Quality Control Plan option for JCAHO Accredited Laboratories (EP Video)
James Halbleib discusses new requirements for IQCP option for clinical laboratories effective Jan. 1, 2016 (22:28 minutes).
Comparison of Local Injection of Platelet Rich Plasma and Corticosteroids in the Treatment of Lateral Epicondylitis of Humerus
This study was conducted with an aim to compare the efficacy of PRP versus methyl-prednisolone local injection in patients with lateral epicondylitis.
Technical Complications During Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange–Retrospective Analysis of 265 Cases
Technical complications are a known hazard in veno-venous extracorporeal membrane oxygenation (vvECMO). Identifying these complications and predictive factors indicating a developing system-exchange was the goal of the study.
Successful Treatment of Severe Carbon Monoxide Poisoning & Refractory Shock Utilizing Cardiohelp ECMO (EP Video)
We present a patient who developed multi-organ failure associated with CO poisoning, and who was successfully supported with veno-arterial (V-A) extracorporeal membrane oxygenation (16:35 minutes).
Successful Treatment of Severe Carbon Monoxide Poisoning & Refractory Shock Utilizing Cardiohelp ECMO (EP Video)
We present a patient who developed multi-organ failure associated with CO poisoning, and who was successfully supported with veno-arterial (V-A) extracorporeal membrane oxygenation (16:35 minutes).
TEG Use for VADs and ECMO (EP Video)
Mike Miller discusses hemostasis from an enzymatic and platelet perspective during ECMO and VADs (33.05 minutes).
TEG Use for VADs and ECMO (EP Video)
Mike Miller discusses hemostasis from an enzymatic and platelet perspective during ECMO and VADs (33.05 minutes).